Blocking NOX-1 enzyme may extend ketamine’s antidepressant effects

Treatment-resistant depression affects a large proportion of people with major depressive disorder, and while ketamine offers rapid relief, its antidepressant effects fade within a few weeks. Now, researchers from Japan have identified the enzyme NOX-1 as a key molecular target to prolong ketamine’s antidepressant effects.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup